ABBV

Q: What is the price of AbbVie (ABBV) today?

The current price of AbbVie (ABBV) is $ 208.42, representing a 22.75% gain over the past year. The stock began the year trading around $ 228.49 and is currently priced at $ 208.42. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does AbbVie (ABBV) pay dividends?

In the last year, AbbVie (ABBV) distributed dividends in the month of February, totaling $ 1.73. The Dividend Yield for the last 12 months is 3.12%.

Q: Is AbbVie (ABBV) a good investment?

AbbVie (ABBV) is currently trading at $ 208.42 with a P/E ratio of 89.02%. This represents a 5,784% premium compared to its historical average P/E. Over the past year, the stock has gained 22.75 and paid $ 1.73 in dividends, resulting in a dividend yield of 3.12%. The total shareholder return over the same period was 22.75%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

AbbVie Inc.

Price

$ 208.42

return (12m)

22.75%

p/e

89.02

p/bv

0.00

DIVIDEND YIELD

3.12%

ABBV price

ABBV

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ABBV

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-5.88%

3 months

-2.34%

1 year

22.75%

2 years

38.43%

5 years

134.31%

10 years

431.69%

Fundamentals ABBV

review the fundamentals of AbbVie shares

P/E

89.02

Sector: -3.96 Industry: -3.96

P/S (PSR)

6.15

Sector: -3.88 Industry: -3.88

P/BV

0.00

Sector: 1.87 Industry: 1.87

DIVIDEND YIELD (DY)

3.12%

Sector: - Industry: -

ROA

0.00%

Sector: -61.39% Industry: -61.39%

ROE

0.00%

Sector: -60.71% Industry: -60.71%

ROIC

11.13%

Sector: -1,194.93% Industry: -1,194.93%

NET MARGIN

6.91%

Sector: -39.39% Industry: -39.39%

GROSS MARGIN

70.24%

Sector: 38.09% Industry: 38.09%

OPERATING MARGIN

30.78%

Sector: -39.58% Industry: -39.58%

EV/EBITDA

22.39

Sector: -3.80 Industry: -3.80

EV/EBIT

35.32

Sector: -4.02 Industry: -4.02

PRICE-TO-ASSETS

Sector: 1.38 Industry: 1.38

BVPS

Sector: 1.89 Industry: 1.89

EPS

2.39

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

1.71%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-18.20%

Sector: - Industry: -

Fundamentals ABBV

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.88	7.40	33.81%	2.14%	$ 586.59 B	28.46%
PFE	20.06	1.67	8.35%	6.28%	$ 155.85 B	12.42%
NVO	10.61	5.46	51.50%	4.98%	$ 166.18 B	33.05%
MRK	16.72	0.00	0.00%	2.70%	$ 305.21 B	28.08%
AZN	31.27	6.56	20.99%	1.55%	$ 319.77 B	17.41%
GILD	20.77	7.81	37.62%	2.24%	$ 176.72 B	28.90%
BMY	16.98	-3.52	-20.72%	4.23%	$ 119.74 B	14.64%
ZTS	19.59	15.72	80.25%	1.70%	$ 52.37 B	28.23%
REGN	17.51	2.52	14.41%	0.47%	$ 78.86 B	31.41%
HALO	24.94	161.91	649.21%	0.00%	$ 7.90 B	22.69%
AMGN	24.97	22.24	89.06%	2.70%	$ 192.51 B	20.98%
MCK	24.84	-1,089.08	-4,383.84%	0.36%	$ 107.82 B	1.09%
VRTX	28.42	6.02	21.18%	0.00%	$ 112.36 B	32.94%
CAH	30.78	-18.95	-61.56%	0.94%	$ 51.16 B	0.68%
HRMY	10.31	1.88	18.24%	0.00%	$ 1.64 B	18.27%
ADMA	16.29	5.01	30.78%	0.00%	$ 2.39 B	28.80%
BIIB	20.21	1.43	7.08%	0.00%	$ 26.12 B	13.07%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ABBV Historical Dividends

current DY: 3.12%

5-year average DY: 3.89%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	04/15/2026	05/15/2026	1,73000000
Dividends	01/16/2026	02/17/2026	1,73000000
Dividends	10/15/2025	11/14/2025	1,64000000
Dividends	07/15/2025	08/15/2025	1,64000000
Dividends	04/15/2025	05/15/2025	1,64000000
Dividends	01/15/2025	02/14/2025	1,64000000
Dividends	10/15/2024	11/15/2024	1,55000000
Dividends	07/15/2024	08/15/2024	1,55000000
Dividends	04/15/2024	05/15/2024	1,55000000
Dividends	01/16/2024	02/15/2024	1,55000000
Dividends	10/13/2023	11/15/2023	1,48000000
Dividends	07/14/2023	08/15/2023	1,48000000
Dividends	04/14/2023	05/15/2023	1,48000000
Dividends	01/13/2023	02/15/2023	1,48000000
Dividends	10/14/2022	11/15/2022	1,41000000
Dividends	07/15/2022	08/15/2022	1,41000000
Dividends	04/15/2022	05/16/2022	1,41000000
Dividends	01/14/2022	02/15/2022	1,41000000
Dividends	10/15/2021	11/15/2021	1,30000000
Dividends	07/15/2021	08/16/2021	1,30000000
Dividends	04/15/2021	05/14/2021	1,30000000
Dividends	01/15/2021	02/16/2021	1,30000000
Dividends	10/15/2020	11/16/2020	1,18000000
Dividends	07/15/2020	08/14/2020	1,18000000
Dividends	04/15/2020	05/15/2020	1,18000000
Dividends	01/15/2020	02/14/2020	1,18000000
Dividends	10/15/2019	11/15/2019	1,07000000
Dividends	07/15/2019	08/15/2019	1,07000000
Dividends	04/15/2019	05/15/2019	1,07000000
Dividends	01/15/2019	02/15/2019	1,07000000
Dividends	10/15/2018	11/15/2018	0,96000000
Dividends	07/13/2018	08/15/2018	0,96000000
Dividends	04/13/2018	05/15/2018	0,96000000
Dividends	01/12/2018	02/15/2018	0,71000000
Dividends	10/13/2017	11/15/2017	0,64000000
Dividends	07/14/2017	08/15/2017	0,64000000
Dividends	04/13/2017	05/15/2017	0,64000000
Dividends	01/13/2017	02/15/2017	0,64000000
Dividends	10/14/2016	11/15/2016	0,57000000
Dividends	07/15/2016	08/15/2016	0,57000000
Dividends	04/15/2016	05/16/2016	0,57000000
Dividends	01/15/2016	02/16/2016	0,57000000
Dividends	10/15/2015	11/16/2015	0,51000000
Dividends	07/15/2015	08/14/2015	0,51000000
Dividends	04/15/2015	05/15/2015	0,51000000
Dividends	01/15/2015	02/13/2015	0,49000000
Dividends	10/15/2014	11/17/2014	0,42000000
Dividends	07/15/2014	08/15/2014	0,42000000
Dividends	04/15/2014	05/15/2014	0,42000000
Dividends	01/15/2014	02/14/2014	0,40000000
Dividends	10/15/2013	11/15/2013	0,40000000
Dividends	07/15/2013	08/15/2013	0,40000000
Dividends	04/15/2013	05/15/2013	0,40000000
Dividends	01/15/2013	02/15/2013	0,40000000

ABOUT AbbVie

AbbVie Inc.

Average Investor10 user rating

5.0 (678 people)

United States

14 years

Founded: 2012

2012

Time since IPO - 14 years

47.000

Employees

AbbVie Inc. is a U.S.-based biopharmaceutical company operating in the Healthcare sector. It focuses on the research, development, and commercialization of innovative medicines. Its shares are traded on the New York Stock Exchange under the ticker ABBV.

AbbVie develops therapies for complex and chronic conditions across multiple therapeutic areas, including:

Immunology: Treatments for autoimmune diseases.
Oncology: Cancer therapies targeting various tumor types.
Neuroscience: Medicines for neurological and psychiatric disorders.
Aesthetics and Specialty Care: Products in medical aesthetics and related fields.

The company generates revenue from a diversified portfolio of biologic and small-molecule therapies and continues to invest heavily in research and development to strengthen its pipeline.

AbbVie operates globally, with commercial, research, and manufacturing facilities across North America, Europe, Asia, and other regions.

History and Development

AbbVie was established in the early 2010s as a spin-off from Abbott Laboratories, allowing it to focus exclusively on innovative biopharmaceutical products.

In its initial years, growth was driven by strong performance in immunology treatments. Over time, the company pursued strategic acquisitions to diversify its portfolio and reduce dependence on individual products.

A major expansion occurred with the acquisition of Allergan, which broadened AbbVie’s presence in aesthetics and neuroscience.

In recent years, AbbVie has focused on expanding its pipeline in oncology, immunology, and neuroscience while addressing patent cycles through product diversification and innovation.

Today, AbbVie remains a major global biopharmaceutical company, centered on advanced therapies and long-term research-driven growth.

Additional Information

AbbVie Inc. (United States) is listed on the NYSE and has a market capitalization of $376.19 Billions, with shareholders equity totaling $-.

The company employs approximately 47.000 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, AbbVie Inc. reported $61.16 Billions in revenue, generating net income of $4.23 Billions.

Key financial metrics include a P/E ratio of 89.02, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 3.12%.

The company trades under the ticker ABBV.

Market cap

$ 376.19 Billions

Net worth

$ -

Assets

$ -

Total Shares Outstanding

1.77 Billion

1,767,000,000

Average Daily Trading Volume

$ 7.16 Millions

$ 7,155,538.14

Sector

Health Care

Industry

Biotechnology

ABBV

revenue by Business Segment AbbVie

Revenue by Region AbbVie

ABBV revenue and profits

Financial Results ABBV

DRAG THE FRAME TO SEE MORE DATA

ABBV cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 863.42 24,78% (12M)

P/E

24.84

0.36%

ROE

-4,383.84%

P/BV

-1,089.08

CAH - Cardinal Health

$ 211.83 59,44% (12M)

P/E

30.78

0.94%

ROE

-61.56%

P/BV

-18.95

JNJ - Johnson & Johnson

$ 238.67 59,39% (12M)

P/E

21.88

2.14%

ROE

33.81%

P/BV

7.40

PFE - Pfizer

$ 27.19 32,32% (12M)

P/E

20.06

6.28%

ROE

8.35%

P/BV

1.67

MRK - Merck & Co.

$ 117.90 59,80% (12M)

P/E

16.72

2.70%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 201.21 51,51% (12M)

P/E

31.27

1.55%

ROE

20.99%

P/BV

6.56

BMY - Bristol-Myers Squibb

$ 57.89 24,48% (12M)

P/E

16.98

4.23%

ROE

-20.72%

P/BV

-3.52

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 863.42 24,78% (12 M)

P/L

24.84

0.36%

ROE

-4,383.84%

P/VP

-1,089.08

CAH - Cardinal Health

$ 211.83 59,44% (12 M)

P/L

30.78

0.94%

ROE

-61.56%

P/VP

-18.95

JNJ - Johnson & Johnson

$ 238.67 59,39% (12 M)

P/L

21.88

2.14%

ROE

33.81%

P/VP

7.40

PFE - Pfizer

$ 27.19 32,32% (12 M)

P/L

20.06

6.28%

ROE

8.35%

P/VP

1.67

MRK - Merck & Co.

$ 117.90 59,80% (12 M)

P/L

16.72

2.70%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 201.21 51,51% (12 M)

P/L

31.27

1.55%

ROE

20.99%

P/VP

6.56

BMY - Bristol-Myers Squibb

$ 57.89 24,48% (12 M)

P/L

16.98

4.23%

ROE

-20.72%

P/VP

-3.52

Frequently Asked Questions

What is the price of AbbVie (ABBV) today?

The current price of AbbVie (ABBV) is $ 208.42, representing a 22.75% gain over the past year. The stock began the year trading around $ 228.49 and is currently priced at $ 208.42. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does AbbVie (ABBV) pay dividends?

In the last year, AbbVie (ABBV) distributed dividends in the month of February, totaling $ 1.73. The Dividend Yield for the last 12 months is 3.12%.

Is AbbVie (ABBV) a good investment?

AbbVie (ABBV) is currently trading at $ 208.42 with a P/E ratio of 89.02%. This represents a 5,784% premium compared to its historical average P/E. Over the past year, the stock has gained 22.75 and paid $ 1.73 in dividends, resulting in a dividend yield of 3.12%. The total shareholder return over the same period was 22.75%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy AbbVie (ABBV) stock?

You can buy AbbVie (ABBV) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ABBV and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of AbbVie (ABBV) yield today?

Over the past month, AbbVie (ABBV) has returned -5.88% — 22.75% over the past year, and 134.31% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 6.65 per share in dividends, resulting in a dividend yield of 3.12%.

If you were to purchase 100 shares of AbbVie (ABBV) today at the current price of $ 208.42 your total investment would be $ 20,842.00.

Based on historical performance, the investment would have grown to approximately:

$ 25,583.56 after 1 year
$ 48,834.89 after 5 years
$ 110,814.83 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ABBV

AbbVie Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ABBV

review the fundamentals of AbbVie shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 3.12%

5-year average DY: 3.89%

type

Ex - Dividend Date

payment date

value

ABOUT AbbVie

AbbVie Inc.

United States

14 years

2012

47.000

History and Development

Additional Information

PROFIT X PRICE ABBV

Financial Results ABBV

ABBV cash flow

Asset, Revenue and Profit Growth - ABBV

ABBV balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

AZN - AstraZeneca

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

AZN - AstraZeneca

BMY - Bristol-Myers Squibb

Frequently Asked Questions